Stock Markets Analysis & Opinion

Last week, EnerSys (NYSE:ENS) reported its first-quarter fiscal 2018 results, wherein it ended its five-quarter long earnings streak with a marginal miss. The company continues grappling with the...

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Del Taco Restaurants Inc. (NASDAQ:TACO) looks promising at the moment. The stock has rallied 18.6% in the last year, outperforming the industry’s gain of 4.9%.In fact, we are positive on this...

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the FDA has granted priority review for the company’s New Drug Application (NDA) for an investigational, fixed-dose combination of...

After scaling to new highs this year, the equity market is showing some cracks. The exchange of bitter words between U.S. and North Korea has kept many traders on their toes, while brick-and-mortar...

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Solar cell manufacturer, Canadian Solar Inc. (NASDAQ:CSIQ) , witnessed second-quarter 2017 adjusted loss of 15 cents per share, narrower than the Zacks Consensus Estimate of a loss of 16 cents. In...

Second quarter earnings season is almost over for the Medical sector with 94.5% of companies belonging to this segment having reported results. A look at the scorecard for Q2 shows that the Medical...

Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn’t want to find stocks that are either flying under the radar and are...

Barracuda Networks, Inc. (NYSE:CUDA) was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than...

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are...

Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are...

We issued an updated report on Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) on Aug 11.In fact, shares of the company have rallied 12.7% against the Zacks classified industry’s fall 3.4% on a...